Markets:

Overview

News

Currencies

International

Treasuries

BioLife Solutions, Inc. - Common Stock (NQ:BLFS)

19.46 -0.66 (-3.26%)

Streaming Delayed Price Updated: 1:56 PM EST, Mar 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioLife Solutions, Inc. - Common Stock

< Previous 1 2 3 Next >

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 08, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 11, 2023 ↗

July 11, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

May 10, 2023

Via Benzinga

BioLife Solns: Q1 Earnings Insights ↗

May 10, 2023

Via Benzinga

BioLife Solutions's Earnings Outlook ↗

March 15, 2023

Via Benzinga

BioLife Solutions's Return On Capital Employed Insights ↗

December 15, 2022

Via Benzinga

Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday ↗

November 11, 2022

Gainers

Via Benzinga

BioLife Solns: Q2 Earnings Insights ↗

August 09, 2022

BioLife Solns (NASDAQ:BLFS) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 10, 2022

Gainers

Via Benzinga

Why Magnite Shares Are Trading Higher By Over 45%? Here Are 69 Stocks Moving In Thursday's Mid-Day Session ↗

November 10, 2022

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares climbed 172% to $0.2769 after dipping 40% on Wednesday. Fast Radius received Bankruptcy court approval of first day motions related to the company's...

Via Benzinga

Earnings Scheduled For February 28, 2022 ↗

February 28, 2022

Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (...

Via Benzinga

Earnings Scheduled For November 11, 2021 ↗

November 11, 2021

Companies Reporting Before The Bell • NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million. • Reshape...

Via Benzinga

Earnings Outlook For BioLife Solutions ↗

November 08, 2022

BioLife Solutions (NASDAQ:BLFS) is set to give its latest quarterly earnings report on Wednesday, 2022-11-09. Here's what investors need to know before the announcement. Analysts estimate that BioLife...

Via Benzinga

Billionaire Israel Englander Is Betting Big on These 5 Stocks ↗

June 24, 2022

Millennium Management's Israel Englander is in focus after the billionaire's fund purchased several stocks this month.

Via InvestorPlace

60 Biggest Movers From Yesterday ↗

April 26, 2022

Gainers Nkarta, Inc. (NASDAQ: NKTX) shares climbed 140.9% to close at $18.72 on Monday after the company announced Phase 1 data from independent dose finding studies of its two...

Via Benzinga

Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday ↗

November 07, 2022

Gainers

Via Benzinga

34 Stocks Moving In Monday's Mid-Day Session ↗

April 25, 2022

Gainers Nkarta, Inc. (NASDAQ: NKTX) shares jumped 108.6% to $16.21 after the company announced Phase 1 data from independent dose finding studies of its two lead chimeric antigen...

Via Benzinga

BioLife Solutions: Q4 Earnings Insights ↗

February 28, 2022

BioLife Solutions (NASDAQ:BLFS) reported its Q4 earnings results on Monday, February 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

BioLife Solutions Inc (BLFS) Q3 2021 Earnings Call Transcript ↗

November 11, 2021

BLFS earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts ↗

November 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Commences Late-Stage Study Of Heart Failure Treatment Merck &...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022 ↗

April 25, 2022

Via Benzinga

Have $500? This Under-the-Radar Stock Could Make You Richer From the Biotech Boom ↗

October 15, 2021

This company is preserving biological material and can help your portfolio grow.

Via The Motley Fool

Stocks That Hit 52-Week Lows On Thursday ↗

February 17, 2022

On Thursday, 147 companies achieved new lows for the year. Significant Points From Today's 52-Week Lows: PayPal Holdings (NASDAQ:PYPL) was the biggest company...

Via Benzinga

Looking Into BioLife Solutions's Return On Capital Employed ↗

September 29, 2021

BioLife Solutions (NASDAQ:BLFS) brought in sales totaling $31.20 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 92.73%, resulting in a...

Via Benzinga

Notable Biolife Solutions Insider Trades $971 Thousand In Company Stock ↗

September 23, 2021

Aby Mathew, Exec VP And Chief Scientific Off at Biolife Solutions (NASDAQ:BLFS), made a large buy and sell of company shares on September 22, according to a new SEC filing. What...

Via Benzinga

Topics Regulatory Compliance

Why Shares in BioLife Solutions Jumped 24.4% in August ↗

September 07, 2021

The company, which specializes in cold-storage solutions for biotechs, had a hot month.

Via The Motley Fool

The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab ↗

September 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV...

Via Benzinga

The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering ↗

September 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31) AC Immune SA (NASDAQ: ACIU...

Via Benzinga

The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical ↗

August 31, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...

Via Benzinga

The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration ↗

August 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...

Via Benzinga

Topics Intellectual Property

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.